Publications by authors named "Marco Affronti"

Claim this Profile
T
Tuberculosis outcomes among international migrants living in Europe compared with the nonmigrant population: A systematic review and meta-analysis.
Sergio Cotugno, Giacomo Guido, Francesco Vladimiro Segala, Luisa Frallonardo, Roberta Papagni, Marco Affronti

IJID Reg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarcopenia increases mortality risk in liver transplantation: a systematic review and meta-analysis.
Konstantinos Prokopidis, Marco Affronti, Giuseppe D Testa, Andrea Ungar, Emanuele Cereda

Panminerva Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma.
Lydia Giannitrapani, Francesca Di Gaudio, Melchiorre Cervello, Francesca Scionti, Domenico Ciliberto, Marco Affronti

Int J Mol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Actively Offering Influenza Vaccination to Frail People during Hospitalisation: A Pilot Study in Italy.
Alessandra Fallucca, Patrizia Ferro, Luca Mazzeo, Luigi Zagra, Elena Cocciola, Marco Affronti

Vaccines (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Addition of an Immunosuppressant After Loss of Response to Anti-TNFα Monotherapy in Inflammatory Bowel Disease: A 2-Year Study.
Fabio Salvatore Macaluso, Chiara Sapienza, Marco Ventimiglia, Sara Renna, Giulia Rizzuto, Marco Affronti

Inflamm Bowel Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience.
Fabio Salvatore Macaluso, Sara Renna, Marcello Maida, Mariangela Dimarco, Chiara Sapienza, Marco Affronti

Scand J Gastroenterol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants.
Fabio Salvatore Macaluso, Marcello Maida, Sara Renna, Emanuele Orlando, Marco Affronti

Dig Liver Dis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders.
Angela Di Salvo, Carmelo Fabiano, Vincenza Mannara, Mariangela Dimarco, Ambrogio Orlando, Marco Affronti

Dig Liver Dis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study.
Ambrogio Orlando, Sara Renna, Filippo Mocciaro, Maria Cappello, Marco Giunta, Marco Affronti

Dig Liver Dis· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Use of Combination Therapy in Patients With Infliximab-resistant Inflammatory Bowel Disease: Data From a Tertiary Referral Center.
Ambrogio Orlando, Sara Renna, Giulia Rizzuto, Emanuele Orlando, Marco Affronti

Clin Gastroenterol Hepatol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of liver disease in a cohort of immigrants in Sicily: analysis of day-hospital admissions in a migration medicine unit.
Marco Affronti, Andrea Affronti, Maurizio Soresi, Lydia Giannitrapani, Elisa Campagna

Infez Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis